Evozyne
Zach Serber is the current COO at Evozyne. Zach was previously the Chief Science Officer, Founder, and Board Member at Zymergen, Inc. from April 2013 to September 2022. Prior to that, they were the Director of Biology at Amyris Inc from August 2011 to February 2013. Zach started at Amyris Inc as a Scientist in September 2007 and held that position until July 2011. Before working in the private sector, Zach was a Research Fellow at Stanford University Medical School from June 2003 to August 2007. Zach began their career as a Physics teacher at Collegiate School from August 1997 to July 1998.
Zach Serber has a PhD in Biophysics from the University of California, San Francisco, an MSc in Neuroscience from The University of Edinburgh, and a BA in Biophysics from Columbia University.
This person is not in any teams
This person is not in any offices
Evozyne
1 followers
Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems. From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world.